Cerity Partners’s Day One Biopharmaceuticals DAWN Stock Holding History

Cerity Partners’s Portfolio DAWN Stock Details DAWN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-18,197	Closed	-$390K	–	3444
2026 Q1	$390K	Buy	18,197 +6,611	+57%	+$93.2K	﹤0.01%	2433
2025 Q4	$108K	Buy	+11,586	New	+$96.8K	﹤0.01%	2736
2025 Q3	–	Sell	-14,417	Closed	-$93.7K	–	2778
2025 Q2	$93.7K	Sell	14,417 -582	-4%	-$4K	﹤0.01%	2490
2025 Q1	$119K	Buy	+14,999	New	+$162K	﹤0.01%	2302

Other funds holding DAWN

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Cerity Partners's DAWN Position: Q2 2026 in Review

Cerity Partners sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 18,197 shares — an estimated $390K sold.

Cerity Partners first reported a position in DAWN in Q1 2025 and held it in 4 quarters. The position peaked at $390K in Q1 2026. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.

Cerity Partners reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
Cerity Partners sold 18,197 Day One Biopharmaceuticals shares in Q2 2026, an estimated $390K.
Cerity Partners first reported a position in Day One Biopharmaceuticals in Q1 2025 and held it in 4 quarters.
Cerity Partners's Day One Biopharmaceuticals position peaked at $390K in Q1 2026.
1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.

Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.